|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-2.43/--
|
企业价值
4.80B
|
资产负债 |
每股账面净值
-3.34
|
现金流量 |
现金流量率
--
|
损益表 |
收益
91.43M
|
每股收益
0.23
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/19 03:23 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to proven treatments for various diseases. |